placebo controlled
Terms related to the query
Term Similarity Weight in brain map N In query
amygdala
0.005229268807258278
1.0
4540 In expansion
hippocampus
0.0029525496663778696
0.6365542336814793
4610 In expansion
cingulate
0.002323676863942613
0.42309480894531487
9501 In expansion
insula
0.001218872270456544
0.31799421078593093
7050 In expansion
thalamus
0.0013475031402197435
0.27376596092375766
4891 In expansion
default
0.001033820739982737
0.08760926808346887
3687 In expansion
brainstem
0.00037763195480290836
0.0665759915510361
1502 In expansion
prefrontal
0.000514674723189805
0.06378464567672167
10017 In expansion
default mode
0.001220698910596897
0.0637397470451498
2555 In expansion
occipital
0.0003090015949601338
0.05567568716606817
6796 In expansion
left
0.000585352384867653
0.038359427790677234
12782 In expansion
motor
0.00018426427197409896
0.036847127288041126
7928 In expansion
precuneus
0.00023483610400122762
0.03556224437112442
5186 In expansion
parietal
0.00013136266469306076
0.034953163134254464
10159 In expansion
striatum
0.000541915027601133
0.03233203771038251
3024 In expansion
parahippocampal
0.0002601566988791239
0.031177789443664148
3512 In expansion
visual
0.0001541556554641936
0.03045860426900789
10448 In expansion
cerebellum
0.00012596190164764328
0.029911126592624473
5578 In expansion
pain
0.0005723498522162149
0.029562490359778
1670 In expansion
temporal
0.00016587638130372828
0.02268343574148829
11897 In expansion
acc
0.0003619787785348815
0.022528918100310637
3579 In expansion
frontal
0.00025406879652801063
0.02228396937697736
11471 In expansion
putamen
0.00028088952568601933
0.020885469801654566
3208 In expansion
m1
0.0002520802338384706
0.020807056346927796
722 In expansion
right
0.000722012292919959
0.019443378785654594
13076 In expansion
auditory
7.23441308470559e-05
0.017346446452528426
4009 In expansion
task
0.0003698745295786234
0.015682658016193646
12194 In expansion
motion
8.944350768304109e-05
0.014633465145048496
9061 In expansion
striatal
0.001037523716077598
0.014415307452274461
2076 In expansion
face
9.662267518072979e-05
0.013474016316769576
4405 In expansion
hand
0.00012980579749979662
0.013462016800613937
7603 In expansion
anterior
0.00022172855442938527
0.011174949541120794
11200 In expansion
superior
0.0001792782567587923
0.010506144191731442
9978 In expansion
orbitofrontal
0.00013553722699427535
0.01027535541785811
3508 In expansion
stimulation
0.0003885183725659002
0.009489825128884941
4565 In expansion
memory
0.0003905445222412738
0.009377752182897225
8405 In expansion
inferior
0.00015596305699191185
0.00875621022756268
10215 In expansion
caudate
0.00013141982721035506
0.008238173803099031
3615 In expansion
dmn
6.378523611335543e-05
0.008092121572287336
1351 In expansion
dlpfc
0.0001069000335645481
0.00763592893226309
2726 In expansion
placebo
0.09792153423997765
0.0
758 In expansion
placebo controlled
1.0
0.0
293 In query
pharmacological
0.004909553016292697
0.0
925 In expansion
receptor
0.004371225713007574
0.0
931 In expansion
mood
0.005234791670554052
0.0
2081 In expansion
meta
0.0034635585653564637
0.0
4053 In expansion
opioid
0.006715993185635979
0.0
212 In expansion
nicotine
0.0045431723614547115
0.0
621 In expansion
stroke
0.0044689445901937574
0.0
1585 In expansion
visceral
0.0038526945688788544
0.0
508 In expansion
women
0.004820739034807129
0.0
2657 In expansion
treatment
0.014985557595868606
0.0
3763 In expansion
schizophrenia
0.006391336864558339
0.0
2513 In expansion
response
0.0034651445418798893
0.0
12421 In expansion
resting
0.0036481656154418343
0.0
4477 In expansion
resting state
0.0033880707336654027
0.0
3327 In expansion
serotonin
0.006256961832228124
0.0
652 In expansion
social
0.006741070250844336
0.0
4519 In expansion
sleep
0.003207305764248894
0.0
828 In expansion
condition
0.0038867737931469973
0.0
11648 In expansion
cerebral
0.005963597796848026
0.0
4338 In expansion
analgesic
0.02929911983047562
0.0
299 In expansion
arterial spin
0.0030696480908501775
0.0
251 In expansion
blind
0.006281630952649407
0.0
1117 In expansion
baseline
0.003889266910097888
0.0
7408 In expansion
blood
0.004172820982954534
0.0
6788 In expansion
induced
0.005024122848254222
0.0
4995 In expansion
infusion
0.00290624914213854
0.0
187 In expansion
healthy
0.0035045010267474577
0.0
10760 In expansion
ht
0.004346170750084202
0.0
168 In expansion
irritable
0.0031299728808174727
0.0
135 In expansion
expectancy
0.004592530934512687
0.0
526 In expansion
expectation
0.008845485493241195
0.0
2133 In expansion
double
0.004406405490706429
0.0
1815 In expansion
dopamine
0.006356558719099095
0.0
1814 In expansion
drug
0.010148180131293474
0.0
3341 In expansion
effect
0.010447671378619178
0.0
13072 In expansion
flow
0.0029510136155438214
0.0
2683 In expansion
Predicted distribution of activations in the literature
Download map
Publications related to the query
Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies
Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial
Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: A randomized, placebo-controlled, double-blind fMRI study
Ketamine interactions with biomarkers of stress: A randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men
L-Dopa Modulates Functional Connectivity in Striatal Cognitive and Motor Networks: A Double-Blind Placebo-Controlled Study
The Cerebral Glucose Metabolic Response to Combined Total Sleep Deprivation and Antidepressant Treatment in Geriatric Depression: A Randomized, Placebo Controlled Study
Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study
GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill—A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive
The effect of flavanol-rich cocoa on cerebral perfusion in healthy older adults during conscious resting state: a placebo controlled, crossover, acute trial
Dopamine-induced changes in neural network patterns supporting aversive conditioning
The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study
Dopaminergic modulation of the reward system in schizophrenia: A placebo-controlled dopamine depletion fMRI study
Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: A randomized placebo‐controlled cross-over study using pharmacological fMRI
Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia
Pomegranate Juice Augments Memory and fMRI Activity in Middle-Aged and Older Adults with Mild Memory Complaints
Influence of single-dose quetiapine on fear network activity – A pharmaco-imaging study
Confidence and psychosis: a neuro-computational account of contingency learning disruption by NMDA blockade
Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease
A Spatiotemporal Profile of In Vivo Cerebral Blood Flow Changes Following Intranasal Oxytocin in Humans
Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo
Daily Carnosine and Anserine Supplementation Alters Verbal Episodic Memory and Resting State Network Connectivity in Healthy Elderly Adults
Effect of paroxetine and bupropion on human resting brain perfusion: An arterial spin labeling study
Acute Effects of Different Multivitamin Mineral Preparations with and without Guaraná on Mood, Cognitive Performance and Functional Brain Activation
The brain signature of paracetamol in healthy volunteers: a double-blind randomized trial
Enhanced Neuroactivation during Verbal Memory Processing in Postmenopausal Women Receiving Short Term Hormone Therapy
Test-Retest Reliability of Memory Task fMRI in Alzheimer’s Disease Clinical Trials